# Prime Medicine Expects About $125 Million in Gross Offering Proceeds

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/54659
Published: 2026-11-11T23:59:18.000Z
Updated: 2026-11-11T23:59:18.000Z
Section: Business

> The company priced 35,714,286 common shares at $3.50 apiece.

Prime Medicine priced 35,714,286 common shares at $3.50 each, and expects the public offering to generate about $125 million in gross proceeds before underwriting discounts, commissions and offering expenses.

The expected proceeds estimate excludes the underwriters’ option to purchase additional shares.